Benjamin L. Ebert, President and CEO at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“This week, Dana-Farber Cancer Institute paid tribute to the extraordinary legacies of three former presidents: Drs. David G. Nathan, Edward J. Benz Jr., and Laurie H. Glimcher at the Past Presidents, Future Promise: An Evening of Celebration event.
As part of the celebration, we announced that a specialty floor in our future cancer hospital – where the most advanced methods of care will be delivered – will be named in tribute to Drs. Nathan, Benz, and Glimcher, through a gift from Anita and Josh Bekenstein, current chair of the Dana-Farber Board of Trustees.
Dana-Farber’s future cancer hospital is possible because of leaders who continually push this institution forward – scientifically, clinically, and in service to patients and their families.
We are grateful to Anita and Josh for the generous gift that makes this named specialty floor possible. Honoring Drs. Nathan, Benz, and Glimcher reflects the extraordinary impact each of them had on Dana-Farber’s evolution and the strong foundation each built for the next generation of cancer research and care.”
Other articles featuring Benjamin L. Ebert on OncoDaily.